InVivoMAb anti-rat CD4 BE0308-R050mg from Bio X Cell | Biocompare.com

Supplier Images

InVivoMAb anti-rat CD4
InVivoMAb anti-rat CD4

InVivoMAb anti-rat CD4

Be the first to write a review!

Citations:

Supplier Page from
Bio X Cell for
InVivoMAb anti-rat CD4

The InVivoMAb anti-rat CD4 Antibody from Bio X Cell is a Mouse Monoclonal antibody to CD4. This antibody recognizes Rat antigen. The InVivoMAb anti-rat CD4 Antibody has been validated for the following applications: Removal, In Vivo, and Flow Cytometry.

Description

Bio X Cell InVivoMAb anti-rat CD4 Monoclonal Antibody has the following reported applications: in vivo CD4+ T cell depletion, Flow cytometry. It features greater than 95% purity, ultra-low endotoxin levels, and are preservative, stabilizer, and carrier protein-free

Product Specs
ItemInVivoMAb anti-rat CD4
CompanyBio X Cell
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBE0308-R050mg
Quantity50 mg
Applicationsin vivo CD4+ T cell depletion, Flow cytometry
ConcentrationLot specific,typically between 4-11 mg/ml
Conjugate/TagUnconjugated
ReactivityRat
TargetCD4
IsotypeIgG2a, κ
CloneOX-38
HostMouse
ImmunogenRat thymocyte glycoproteins
NCBI Full Gene NameCd4 molecule
NCBI Gene AliasesW3/25, p55
ClonalityMonoclonal
Antibody TypePrimary Antibody
Purity>95%, Determined by SDS-PAGE
FormatPBS, pH 7.0, Contains no stabilizers or preservatives
Research AreaImmunology

Specifications/Features

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

Add to Compare List

Bio X Cell

Bio X Cell

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

Company Profile

Website: bioxcell.com

(1) Vaccination to prevent T cell subversion can protect against persistent hepacivirus infectionNature communicationsMarch 7, 2019Hartlage AS, Murthy S, Kumar A, Trivedi S, Dravid P, Sharma H, Walker CM, Kapoor A.

(2) Distribution of bone-marrow-derived endothelial and immune cells in a murine colitis-associated colorectal cancer modelPloS oneJanuary 1, 2013Xiao CX, Wang HH, Shi Y, Li P, Liu YP, Ren JL, Guleng B.

(3) Permanent CNI treatment for prevention of renal allograft rejection in sensitized hosts can be replaced by regulatory T cellsAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsSeptember 1, 2012Siepert A, Ahrlich S, Vogt K, Appelt C, Stanko K, Kühl A, van den Brandt J, Reichardt HM, Nizze H, Lehmann M, et al.

(4) Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strainsInfection and immunityApril 1, 2011Mara-Koosham G, Hutt JA, Lyons CR, Wu TH.

(5) alpha1,2Fucosyltransferase increases resistance to apoptosis of rat colon carcinoma cellsGlycobiologyApril 1, 2000Goupille C, Marionneau S, Bureau V, Hallouin F, Meichenin M, Rocher J, Le Pendu J.

(6) Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the ratInternational journal of radiation biologyMay 1, 1999Westermann W, Schöbl R, Rieber EP, Frank KH.

(7) Single dose anti-CD4 monoclonal antibody for induction of tolerance to cardiac allograft in high- and low-responder rat strain combinationsTransplant immunologySeptember 1, 1997Qi Z, Riesbeck K, Ostraat O, Tufveson G, Ekberg H.

Be the First to Write a Review!